Sirtex Medical

Listen to Dr. Joseph DeMarco's POV on how SIR-Spheres® provides flexibility when trying to prevent disease progression. ⬇️ Common side effects include abdominal pain, nausea, and constipation. For more SIR-Spheres® Safety Info click: sirtex.com/sir-spheres/risks…

“LAVA® That!” is more than a tagline. It's an embolization strategy for peripheral arterial hemorrhage. With convenient volume and viscosity options, minimal vessel size restriction and quick preparation, this liquid embolic sets itself apart for physicians looking to stop bleeds quickly. If you haven't used the LAVA® Liquid Embolic System yet, our team is happy to share some upcoming hands-on learning opportunities. Learn more here: sirtex.com/us/products/lava-… Potential adverse effects may include allergic reactions to device components and pain at access site. See LAVA® Safety Info: bit.ly/3QJPvUy

The MARCH-HCC abstract, presented by doctors @AmmarSarwarIRad and Dr. Nima Kokabi, adds to the growing body of research evaluating resin Y-90 for the treatment of hepatocellular carcinoma (HCC) patients. With 79% of tumors evaluated achieving complete pathological necrosis, this study has presented Y-90 resin as a viable option for bridging to transplantation or downstaging to surgical resection. Common side effects include abdominal pain, nausea, and constipation. For more SIR-Spheres® Safety Info click: bit.ly/4eZ2dsO

No two labs are exactly alike, and that’s what makes every opportunity to “LAVA That!” unique. June kept the momentum going for our LAVA® Hands-On Training Labs, with physicians and care teams across the country coming together to explore the evolving role of liquid embolization through peer-to-peer education and hands-on learning. From live demonstrations to collaborative discussions around technique and real-world application, each stop created new opportunities to share expertise and help clinicians build confidence with the LAVA® Liquid Embolic System. Interested in attending a future LAVA® Lab? Reach out to your local Sirtex representative to learn where we’re headed next.

Congratulations to Dr. Oleksandra Kutsenko for completing her 100th Y-90 radioembolization treatment! This is a major milestone for both Dr. Kutsenko and the Y-90 field as a whole and we're honored to support this incredible achievement.

We're excited to shine a spotlight on Onvida Health’s first Y-90 procedure that reflects the growing momentum around tailored, minimally invasive liver-directed therapies for hepatocellular carcinoma and advanced colorectal cancer that metastasized to her liver. See the full story here: bit.ly/3RBph73

Thank you to the physicians who discussed all things resin Y-90 with us at this year’s @SIO_Central NEXT Summit at the @UChicago. Together, we're driving the evolution of multidisciplinary care and emerging treatment strategies across interventional oncology.

How effective is treating unresectable hepatocellular carcinoma with Y-90 selective internal radiation therapy using partition dosimetry? The #DOORwaY90 study, led by PIs Dr. Armeen Mahvash and Dr. Cheenu Kappadath, answers with compelling evidence for SIR-Spheres® Y-90 resin microspheres. Read more about the results here: sirtex.com/us/products/sir-s… Common side effects include abdominal pain, nausea, and constipation. For more SIR-Spheres® Safety Info click: bit.ly/4eZ2dsO

We don't just partner with physicians, we collaborate with them. For years, our team has proudly worked alongside @KUHospital to move the Y-90 space forward. Collaborating directly with physicians, like Zachary Collins, MD, FSIR, has provided access to real world feedback that helps us all improve the patient treatment experience. Dr. Collins and the other industry leaders we partner with are helping expand what's possible in Y-90 therapy and liquid embolization. We're grateful for long-standing relationships like these, and for the physicians who push us to deliver innovative solutions.

That's a wrap on a successful @thegestgroup Annual Meeting! We appreciate everyone who stopped by our booth and are especially grateful for Dr. @ZTBerman, Dr. @AmmarSarwarIRad and Dr. @riadsalemIR for kicking off the weekend with their presentation on advancing Y-90 in HCC treatment. It’s a privilege to support a dynamic forum that brings together the interventional radiology and oncology communities. We look forward to continuing the conversations and momentum sparked over the weekend.

Shining a spotlight our recent Center of Education program at the University of Kentucky! This kicked off with a multidisciplinary tumor board that worked through complex HCC cases where attendees examined treatment challenges, evaluated options and assessed outcomes in real time. The clinical sessions that followed gave fellows hands-on experience with Y-90 resin mapping, case reviews, dosimetry and technique refinement. When educators, clinicians and industry stakeholders collaborate and have this kind of thoughtful clinical dialogue, we all gain the knowledge and confidence that advances patient care. Our thanks to Dr. Driss Raissi for hosting and moderating this program, and to every physician who contributed their expertise!

Another inspiring year at the @SIRspecialists Annual Meeting has come to a close, and we’re grateful for the opportunity to connect with so many peers across the interventional radiology community. From sharing new insights on the #DOORwaY90 study to welcoming attendees into our LAVA® Mobile Education Center and sponsoring a symposium on data and trends using Y-90 resin microspheres in radiation segmentectomies for the treatment of HCC, #SIR26TOR was filled with meaningful moments of collaboration, learning and innovation. Looking forward to continuing these conversations, expanding our relationships and advancing the field together.

ICYMI: Dr. Armeen Mahvash and Dr. Cheenu Kappadath's #DOORwaY90 study was just released, with key data points including: 🔹100% local tumor control 🔹90% complete response rate 🔹99% best overall response rate Read more about the #DOORwaY90 data here: sirtex.com/us/news/press-rel… Common side effects include abdominal pain, nausea, and constipation. For more SIR-Spheres® Safety Info click: sirtex.com/sir-spheres/risks…

It's the final day of #SIR26TOR, but there's still plenty to learn! Join us today, April 14, from 12:10pm - 1:10pm ET, for a Lunch Symposium covering the latest data and trends using Y-90 resin microspheres in radiation segmentectomies for the treatment of HCC. Dr. William Rilling will moderate a discussion between Dr. Ammar Sarwar and Dr. @NimaKokabiMD. Stop by Booth 1123 to learn how you can get any dose, any day. With SIR-Spheres®, it's as seamless as ordering today and treating tomorrow. @SIRspecialists Common side effects include abdominal pain, nausea, and constipation. For more SIR-Spheres® Safety Info click: sirtex.com/sir-spheres/risks…

Need a coffee break at #SIR26TOR? ☕ Stop by Booth 1123 at the @SIRspecialists Annual Meeting to grab a cup and connect with the Sirtex team. We’re excited to welcome attendees throughout the conference to explore our technology, see live demos and talk with our experts.

We're thrilled to kick off day two of #SIR26TOR by releasing the 12-month results of the #DOORwaY90 study! These results truly set the bar for Y-90 selective internal radiation therapy using partition dosimetry in patients with unresectable hepatocellular carcinoma, expanding what's possible in liver-directed therapy. Thank you to all of the physicians and partners who contributed to this study over the years - your commitment and dedication is what moves this field forward. Read more about the #DOORwaY90 study results here: sirtex.com/us/news/press-rel… Common side effects include abdominal pain, nausea, and constipation. For more SIR-Spheres® Safety Info click: sirtex.com/sir-spheres/risks…

A packed room at #SIR26TOR as Dr. Armeen Mahvash presented the #DOORwaY90 Late-Breaking Abstract and discussed its implications for the field at the @SIRspecialists Annual Meeting. Great to see the energy and engagement around this important research. Check in tomorrow for more #DOORwaY90 data!

Last call to step inside the LAVA® Mobile Education Center experience at #SIR26TOR. If you’re attending the @SIRspecialists Annual Meeting, stop by today for hands-on, expert guided education with the LAVA® liquid embolic. If there's a bleed, LAVA THAT! Secure your spot here: bit.ly/4mjksuG

The @SIRspecialists Annual Meeting in Toronto is finally here! Stop by Booth 1123 to experience a live demo of SIR-Spheres® Y-90 resin microspheres or the LAVA® liquid embolic. We’re looking forward to a few inspiring days of collaboration, education and innovation. #SIR26TOR

The LAVA® Mobile Education Center is on the ground in Toronto! Our team has brought this hands-on educational opportunity to @SIRspecialists Annual Meeting and will be available this Saturday, April 11 and Sunday, April 12 only. Stop by to see and learn what it’s like to complete an embolization using the LAVA® Liquid Embolic and connect with our team. If there's a bleed, LAVA THAT! You can register for a time slot here: bit.ly/4mjksuG